MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: ConvaTec completes acquisition of wound care business Triad

ALN

ConvaTec Group PLC - Reading, England-based medical products and technologies company - Completes $125 million acquisition of Triad Life Sciences Inc, a Memphis, Tennessee-based company focused on developing biological products for surgical wounds. Triad's portfolio and product pipeline will now be absorbed into ConvaTec's Advanced Wound Care business, and become known as ConvaTec Advanced Tissue Technology.

In the two years post-completion, there are two earnout payments conditional on Triad's performance, up to a maximum earnout of $275 million.

Current stock price: 178.55 pence, up 1.3% on Monday

12-month change: down 7.0%

Copyright 2022 Alliance News Limited. All Rights Reserved.